In March 2020, the Regulatory Focus editorial team was eager to find a way to meet the information needs of RAPS members and the regulatory community as the reality of a coronavirus pandemic set in.

The COVID-19 vaccine, its widespread distribution and eventual herd immunity are the keys to recovering from the coronavirus pandemic and getting back to normal. At least that's the light on the ...

The Food and Drug Administration could fully approve the two-dose Pfizer COVID-19 vaccine as early as Monday, according to multiple reports. Pfizer, Moderna, and Johnson & Johnson are currently ...

Aug 30 (Reuters) - The head of the U.S. Food and Drug Administration (FDA) is willing to fast-track a COVID-19 vaccine as quickly as possible, the Financial Times reported him as saying in an ...

States are rolling back lockdowns, but the coronavirus isn't done with the U.S. Cases are rising in nearly half the states, according to an Associated Press analysis, a worrying trend that could ...

ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head studyFirst head-to-head, double-blind, ...